NUFARM LIMITED, A.C.N. 004 377 780 – Trademark Portfolio
Entity Type: 99
NUFARM LIMITED, A.C.N. 004 377 780 holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 4 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include N and NUFARM. The owner is based in Laverton North, Victoria.
103-105 Pipe Road
Laverton North, Victoria , AU
Showing of trademarks Trademarks
Trademark Classifications
NUFARM LIMITED, A.C.N. 004 377 780's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does NUFARM LIMITED, A.C.N. 004 377 780 have?
NUFARM LIMITED, A.C.N. 004 377 780 has 4 U.S. trademarks filed with the USPTO. Of these, 2 registered, 2 abandoned.
What trademark classes does NUFARM LIMITED, A.C.N. 004 377 780 file in?
NUFARM LIMITED, A.C.N. 004 377 780 files trademarks across 2 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 5 (Pharmaceuticals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are NUFARM LIMITED, A.C.N. 004 377 780's most well-known trademarks?
NUFARM LIMITED, A.C.N. 004 377 780's registered trademark portfolio includes well-known marks such as N and NUFARM. These are among 2 currently registered trademarks in the portfolio.
What is NUFARM LIMITED, A.C.N. 004 377 780's trademark registration success rate?
NUFARM LIMITED, A.C.N. 004 377 780 has a 50% trademark registration rate, with 2 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.